- AU$19.15m
- -AU$14.02m
- AU$0.23m
Brief: Opthea Says Hamish George Assumes Role Of CFO
Brief: Opthea Logs FY Prelim Loss Attributable $162.8 Mln
Australia's Opthea cuts 80% staff, key executives to exit in deal to avert bankruptcy (updated)
Brief: Opthea Says CEO Fred Guerard To Step Down
Australia's Opthea announces 80% headcount reduction, management overhaul
Brief: Opthea Says Reducing Workforce By 65%
Brief: Opthea Ltd Announces Decision To Discontinue Wet AMD Trials
Australia's Regal Asian Investments falls on devaluing Opthea stake
Brief: Opthea Say Coast Phase 3 Trial Fails To Meet Primary Endpoint
Brief: Opthea Seeks Trading Halt
Brief: Opthea Says HY Loss From Ordinary Activities Before Tax Increased To $137.9 Million
Brief: Opthea Appoints Tom Reilly As CFO
Brief: Opthea Says Daniel Geffken Appointed CFO Ad Interim
Brief: Opthea Announces Publication On VEGF-C And D Signaling Pathways As Potential Targets For Treatment Of Wet AMD
Australia's Opthea slumps most in over 4 years on discounted placement
Brief: Opthea To Raise Up To A$227.3 Million
Brief: Opthea Says Seeks Trading Halt
Brief: Opthea Seeks Trading Halt
Brief: Opthea Completes Enrollment In Pivotal Phase 3 Clinical Program With Sozinibercept In Wet AMD